NetworkNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) to Participate in Cantor 2026 Global Healthcare Conference
Tonix Pharmaceuticals (NASDAQ: TNXP) announced its management team will participate in a fireside chat and one-on-one meetings at Cantor’s 2026 Global Healthcare Conference, being held Sept. 9-11, 2026, in New York. President and CEO Seth Lederman, M.D., will present Sept. 10 from 3:55-4:25 p.m. ET, with a live webcast and replay available through the Investors section of the Tonix website. To view the full press release, visit https://nnw.fm/hajiz Tonix Pharmaceuticals Holding Corp. Tonix Pharmaceuticals is a fully-integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA(TM) (cyclobenzaprine HCl sublingual…







